Metabolic studies and preclinical evaluation of priority 19/18F-biomolecules

UOXF and JANb will generate a number of novel 19F- and 18F-fluorinated fragments and biomolecules, for which metabolic stability is unclear or unknown, and will require systematic investigation. All ESRs will be involved.